Literature DB >> 9819299

Ganglioside GQ1b enhances Ig production by human PBMCs.

N Kanda1, K Tamaki.   

Abstract

BACKGROUND: Gangliosides are glycosphingolipids that contain sialic acid and have various immunomodulatory effects.
OBJECTIVE: We studied in vitro effects of gangliosides on human humoral immune responses.
METHODS: PBMCs from healthy volunteers were cultured with gangliosides GM1, GM2, GM3, GD1a, GD1b, GD2, GD3, GT1b, and GQ1b. The amounts of IgG, IgM, and IgA and cytokine activity in the culture supernatants were measured with use of an ELISA. Proliferation was determined by [3H] thymidine uptake.
RESULTS: Among the various gangliosides tested, GQ1b most strongly enhanced spontaneous IgG, IgM, and IgA production by human PBMCs. The effect of GQ1b was revealed at 0.1 micromol/L, increased dose dependently, and was maximized at 10 micromol/L. Weaker but significant stimulatory effects on the Ig production were manifested by GM2 and GD1a, whereas GT1b and GD1b were inhibitory. None of the gangliosides examined affected the proliferation of PBMCs. GQ1b did not enhance Ig production of B cells alone. Anti-IL-6 and anti-IL-10 antibody each partially blocked GQ1b-induced enhancement of the Ig production by PBMCs, and the addition of both antibodies completely blocked the enhancement. GQ1b enhanced both IL-6 and IL-10 production of T cells without affecting those of monocytes or B cells. GQ1b enhanced Ig production of T and B cell culture without monocytes. When T cells were preincubated with GQ1b, washed and added to B cells and monocytes, and then cultured together, the Ig production was also enhanced, although to a lesser extent than the whole time incubation. Exogenous IL-6 and IL-10 each enhanced Ig production of B cells alone, and the addition of both gave additive effects.
CONCLUSION: These results suggest that GQ1b may indirectly enhance Ig production of B cells by promoting IL-6 and IL-10 production of T cells in whole PBMC culture. That GQ1b may act as an important immunostimulator is also indicated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819299     DOI: 10.1016/s0091-6749(98)70022-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

1.  Ganglioside GT1b suppresses immunoglobulin production by human peripheral blood mononuclear cells.

Authors:  N Kanda; K Tamaki
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

2.  Human leukocytes regulate ganglioside expression in cultured micro-pig aortic endothelial cells.

Authors:  Jin-Hyoung Cho; Ji-Su Kim; Malg-Um Lim; Hyun-Ki Min; Dong-Hoon Kwak; Jae-Sung Ryu; Ju-Taek Lee; Sun-Uk Kim; Chang-Hwan Kim; Chang-Hyun Kim; Deog-Bon Koo; Kyu-Tae Chang; Young-Kug Choo
Journal:  Lab Anim Res       Date:  2012-12-26

3.  Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid.

Authors:  S Hettmer; R McCarter; S Ladisch; K Kaucic
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

Review 4.  Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents.

Authors:  Jose Luis Daniotti; Ricardo D Lardone; Aldo A Vilcaes
Journal:  Front Oncol       Date:  2016-01-07       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.